OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 1, pp. 15-29
Open Access | Times Cited: 330
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 1, pp. 15-29
Open Access | Times Cited: 330
Showing 1-25 of 330 citing articles:
Systemic Lupus Erythematosus
Caroline H. Siegel, Lisa R. Sammaritano
JAMA (2024) Vol. 331, Iss. 17, pp. 1480-1480
Closed Access | Times Cited: 65
Caroline H. Siegel, Lisa R. Sammaritano
JAMA (2024) Vol. 331, Iss. 17, pp. 1480-1480
Closed Access | Times Cited: 65
Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakiset al
Antonis Fanouriakis, Myrto Kostopoulou, George Βertsias, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 10, pp. e19-e19
Open Access | Times Cited: 35
Antonis Fanouriakis, Myrto Kostopoulou, George Βertsias, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 10, pp. e19-e19
Open Access | Times Cited: 35
Advancements and challenges in CAR T cell therapy in autoimmune diseases
Georg Schett, Fabian Müller, Jule Taubmann, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 9, pp. 531-544
Closed Access | Times Cited: 28
Georg Schett, Fabian Müller, Jule Taubmann, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 9, pp. 531-544
Closed Access | Times Cited: 28
Clinical implications of human Parvovirus B19 infection on autoimmunity and autoimmune diseases
Chih-Chen Tzang, Liang-Yun Chi, Chenyu Lee, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113960-113960
Closed Access | Times Cited: 1
Chih-Chen Tzang, Liang-Yun Chi, Chenyu Lee, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113960-113960
Closed Access | Times Cited: 1
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study
Spyridon Katechis, Sofia Pitsigavdaki, Myrto Nikoloudaki, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e005118-e005118
Open Access | Times Cited: 1
Spyridon Katechis, Sofia Pitsigavdaki, Myrto Nikoloudaki, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e005118-e005118
Open Access | Times Cited: 1
Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study
Yi‐Ting Chen, Xin Lei, Jianhang Xu, et al.
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001296-e001296
Open Access | Times Cited: 1
Yi‐Ting Chen, Xin Lei, Jianhang Xu, et al.
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001296-e001296
Open Access | Times Cited: 1
Late-onset Systemic Lupus Erythematosus
Prakashini Mruthyunjaya, Sakir Ahmed, Aliya Botabekova, et al.
Rheumatology International (2025) Vol. 45, Iss. 1
Closed Access | Times Cited: 1
Prakashini Mruthyunjaya, Sakir Ahmed, Aliya Botabekova, et al.
Rheumatology International (2025) Vol. 45, Iss. 1
Closed Access | Times Cited: 1
Real-world oral glucocorticoid use in SLE: a nation-wide population-based study using the French medico-administrative (SNDS) claim database
Laurent Arnaud, C. Fabry-Vendrand, R. Todea, et al.
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001428-e001428
Open Access | Times Cited: 1
Laurent Arnaud, C. Fabry-Vendrand, R. Todea, et al.
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001428-e001428
Open Access | Times Cited: 1
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study
Cynthia Aranow, Cornelia F Allaart, Zahir Amoura, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225686
Open Access | Times Cited: 13
Cynthia Aranow, Cornelia F Allaart, Zahir Amoura, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225686
Open Access | Times Cited: 13
B-cell depletion in autoimmune diseases
Georg Schett, György Nagy, Gerhard Krönke, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225727
Closed Access | Times Cited: 12
Georg Schett, György Nagy, Gerhard Krönke, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225727
Closed Access | Times Cited: 12
Lupus nephritis-related chronic kidney disease
Julia Lichtnekert, Hans‐Joachim Anders
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 11, pp. 699-711
Closed Access | Times Cited: 11
Julia Lichtnekert, Hans‐Joachim Anders
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 11, pp. 699-711
Closed Access | Times Cited: 11
Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus
Yasuto Araki, Toshihide Mimura
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1019-1019
Open Access | Times Cited: 9
Yasuto Araki, Toshihide Mimura
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1019-1019
Open Access | Times Cited: 9
Clinical and laboratory characteristics of early-onset and delayed-onset lupus nephritis patients: A single-center retrospective study
Joanna Kosałka-Węgiel, Radosław Dziedzic, Andżelika Siwiec-Koźlik, et al.
Rheumatology International (2024) Vol. 44, Iss. 7, pp. 1283-1294
Open Access | Times Cited: 9
Joanna Kosałka-Węgiel, Radosław Dziedzic, Andżelika Siwiec-Koźlik, et al.
Rheumatology International (2024) Vol. 44, Iss. 7, pp. 1283-1294
Open Access | Times Cited: 9
Systemic Lupus Erythematosus
Gráinne Murphy, David Isenberg
Elsevier eBooks (2024)
Closed Access | Times Cited: 9
Gráinne Murphy, David Isenberg
Elsevier eBooks (2024)
Closed Access | Times Cited: 9
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort
Ioannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 7, pp. 889-900
Open Access | Times Cited: 8
Ioannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 7, pp. 889-900
Open Access | Times Cited: 8
Novel and potential future therapeutic options in systemic autoimmune diseases
Lili Balogh, Katalin Oláh, Soma Sánta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Lili Balogh, Katalin Oláh, Soma Sánta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations
Myrto Kostopoulou, Chetan Mukhtyar, George Βertsias, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225319
Open Access | Times Cited: 7
Myrto Kostopoulou, Chetan Mukhtyar, George Βertsias, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225319
Open Access | Times Cited: 7
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry
Mar Riveiro‐Barciela, Ana Barreira‐Díaz, Paula Esteban García, et al.
Liver International (2024) Vol. 44, Iss. 9, pp. 2303-2314
Closed Access | Times Cited: 7
Mar Riveiro‐Barciela, Ana Barreira‐Díaz, Paula Esteban García, et al.
Liver International (2024) Vol. 44, Iss. 9, pp. 2303-2314
Closed Access | Times Cited: 7
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study
Yasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 8, pp. 998-1005
Closed Access | Times Cited: 6
Yasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 8, pp. 998-1005
Closed Access | Times Cited: 6
Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis
Ioannis Parodis, Julius Lindblom, Daniel Toro‐Domínguez, et al.
Kidney International Reports (2024) Vol. 9, Iss. 6, pp. 1817-1835
Open Access | Times Cited: 6
Ioannis Parodis, Julius Lindblom, Daniel Toro‐Domínguez, et al.
Kidney International Reports (2024) Vol. 9, Iss. 6, pp. 1817-1835
Open Access | Times Cited: 6
Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study
Vera Golder, Rangi Kandane‐Rathnayake, Ning Li, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 8, pp. e528-e536
Closed Access | Times Cited: 6
Vera Golder, Rangi Kandane‐Rathnayake, Ning Li, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 8, pp. e528-e536
Closed Access | Times Cited: 6
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial
Joan T. Merrill, Yoshiya Tanaka, David D’Cruz, et al.
Arthritis & Rheumatology (2024)
Open Access | Times Cited: 6
Joan T. Merrill, Yoshiya Tanaka, David D’Cruz, et al.
Arthritis & Rheumatology (2024)
Open Access | Times Cited: 6
Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy
Yogita Ghodke‐Puranik, Mikhail Olferiev, Mary K. Crow
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 635-648
Closed Access | Times Cited: 6
Yogita Ghodke‐Puranik, Mikhail Olferiev, Mary K. Crow
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 635-648
Closed Access | Times Cited: 6
CAR-T cells for treating systemic lupus erythematosus: A promising emerging therapy
Aurélien Guffroy, Léa Jacquel, Blandine Guffroy, et al.
Joint Bone Spine (2024) Vol. 91, Iss. 5, pp. 105702-105702
Open Access | Times Cited: 5
Aurélien Guffroy, Léa Jacquel, Blandine Guffroy, et al.
Joint Bone Spine (2024) Vol. 91, Iss. 5, pp. 105702-105702
Open Access | Times Cited: 5
Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up
Ioannis Parodis, Thomas Stephens, Annica Dominicus, et al.
Lara D. Veeken (2024)
Open Access | Times Cited: 5
Ioannis Parodis, Thomas Stephens, Annica Dominicus, et al.
Lara D. Veeken (2024)
Open Access | Times Cited: 5
